Titan Biotech opened higher at ₹372.70, compared with its previous close of ₹368.70. In the last trading session on 12 Nov 2026, the stock traded between ₹367.05 and ₹379.00, with an average traded price of ₹373.53. It showed a sideways intraday trend.
An investment of ₹10,000 made 5 years ago in Titan Biotech is now worth
₹ 75,947.00
Giving a profit of
₹ 65,947.00 (659.47%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
+2.30 (+0.62%)
Day High
₹379.00
Day Low
₹367.05
Day Open
₹372.70
Prev Close
₹368.70
Volume
44,351
Value Traded
₹1.66 Cr
1W Return
14.95%
1M Return
18.12%
3M Return
16.46%
6M Return
0.34%
1Y Return
148.26%
Market Cap (₹ Cr.)
1,916
PE Ratio
49.20
PB Ratio
9.39
Dividend Yield
0.14%
ROE
15.12%
ROCE
20.80%
Book Value (₹)
39.27
Face Value (₹)
2.00
EPS (TTM)
3.04
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
14.95%
6 Weeks
-
1 Month
18.12%
3 Months
16.46%
9 Months
109.24%
Titan Biotech Q2FY27 Results: Net profit rises 65% YoY to ₹1,133 lakh
Standalone net profit rose 65.1% YoY to ₹1,133.07 lakh in Q2FY27. Revenue from operations grew 40.7% YoY to ₹7,646.25 lakh. Consolidated net profit increased 61.6% YoY to ₹1,254.78 lakh. Operating cash flow improved to ₹1,288.43 lakh for H1FY27. Basic EPS declined to ₹2.74 due to share capital dilution despite profit growth.
7 days agoTitan Biotech allots 1.03 crore bonus shares in 1:4 ratio
Allotted 1,03,29,625 bonus shares in a 1:4 ratio. Record date fixed at October 23, 2026. Paid-up capital rises from ₹8.26 crore to ₹10.33 crore. Board approved allotment on October 26, 2026.
18 days agoTitan Biotech fixes Oct 23 record date for 1:4 bonus share issue
Record date fixed for October 23, 2026. Bonus ratio set at 1:4 with face value of ₹2. Total 1,03,29,625 shares to be issued. Deemed allotment date is October 26, 2026. Shares tradable from October 27, 2026.
1mo agoTitan Biotech shareholders approve bonus issue and capital increase at 34th AGM
Titan Biotech approved bonus issue and authorized capital increase at 34th AGM. All 10 resolutions passed, including loan authorization and property mortgage. Promoter group held 55.78% of outstanding shares, influencing voting outcomes. Total votes polled for key resolutions ranged from 2.08 crore to 2.36 crore.
1mo agoTitan Biotech schedules 34th AGM for September 29, 2026
Titan Biotech publishes AGM notices in Financial Express and Naya India. 34th AGM scheduled for September 29, 2026, via Video Conferencing. E-voting window runs from September 26 to September 28, 2026. Record date for dividend eligibility set for September 22, 2026.
2mo agoTitan Biotech fixes Sep 22 as record date for ₹0.50 final dividend
Titan Biotech fixed September 22, 2026, as the record date for the FY26 final dividend. The Board recommended a payout of ₹0.50 per equity share of face value ₹2. The dividend requires approval at the upcoming 34th Annual General Meeting. Payment will follow the AGM, subject to applicable tax deductions.
2mo ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹19,420.00 | +0.75% | ₹1,75,731.69 | 74.40 | +37.89% | |
| ₹1,550.50 | -1.85% | ₹1,57,822.25 | 59.10 | +4.62% | |
| ₹2,472.50 | -0.18% | ₹73,291.04 | 32.30 | -15.94% | |
| ₹6,823.00 | +0.27% | ₹58,189.43 | 117.40 | +17.62% | |
| ₹4,776.10 | -0.79% | ₹52,465.46 | 79.80 | +29.10% | |
| ₹10,060.50 | +0.92% | ₹51,602.69 | 56.20 | +67.05% | |
| ₹557.30 | -0.93% | ₹28,119.92 | 33.00 | +21.20% | |
| ₹1,671.20 | -1.08% | ₹22,181.48 | 89.90 | +124.73% | |
| ₹1,602.80 | -1.38% | ₹21,861.08 | 20.90 | -7.14% | |
| ₹484.35 | +0.09% | ₹17,562.26 | 29.60 | +21.97% | |
| ₹5,339.00 | +0.12% | ₹16,369.36 | 34.00 | +25.06% | |
| ₹1,246.30 | -0.93% | ₹15,733.02 | 16.10 | -10.54% |
An investment of ₹10,000 made 5 years ago in Titan Biotech is now worth
₹ 75,947.00
Giving a profit of
₹ 65,947.00 (659.47%)
Note: Past profits do not guarantee future returns.
